Co-trimoxazole

Co-trimoxazole, formulated at 400mg+80mg, is a combination antibacterial active against a broad range of organisms including Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, E. coli, Klebsiella, Salmonella, Proteus, Shigella, Neisseria gonorrhoeae, N. meningitidis, and Haemophilus influenzae, with notably stronger activity against E. coli, H. influenzae, and S. aureus than sulfamethoxazole alone; it also shows in vitro activity against Chlamydia trachomatis, Nocardia asteroides, and Toxoplasma gondii. Cisen Pharmaceutical Co., Ltd. manufactures it directly to in-house standards, provides samples, and distributes it across North America, Central/South America, Europe, Australasia, Asia, the Middle East, and Africa.